Oryzon Genomics S.A. (ORN) - Financials, balance sheet (quarterly)

2.66500 EUR

0.1

3.90%

Last update May 21, 8:09 AM CEST

Market closed

Day range

2.66500

Previous close

2.56500

Open

2.66500

Access this stock data via API

Oryzon Genomics S.A.

2.67

0.10

3.90%

Financials

Balance sheet

Fiscal date	Sep 2024	Jun 2024	Mar 2024	Dec 2023
Total assets	122.7M	110.7M	96.0M	106.9M
Current assets	—	13.9M	9.5M	14.3M
Cash	—	10.1M	—	12.3M
Cash equivalents	—	—	—	—
Cash and cash equivalents	8.4M	10.1M	9.5M	12.3M
Other short term investments	—	—	—	—
Accounts receivable	—	1.1M	—	1.4M
Other receivables	—	1.0M	—	647.0K
Inventory	—	7.1K	—	6.0K
Prepaid assets	—	—	—	—
Restricted cash	—	—	—	—
Assets held for sale	—	—	—	—
Hedging assets	—	—	—	—
Other current assets	—	—	—	—
Non current assets	—	96.8M	86.4M	92.6M
Properties	—	1.1M	—	1.1M
Land and improvements	—	—	—	—
Machinery furniture equipment	—	1.6M	—	1.6M
Construction in progress	—	—	—	—
Leases	—	—	—	—
Accumulated depreciation	—	-2.3M	—	-2.2M
Goodwill	—	94.0M	—	89.9M
Investment properties	—	—	—	—
Financial assets	—	—	—	—
Intangible assets	—	94.0M	—	89.9M
Investments and advances	—	—	—	—
Other non current assets	—	—	—	—
Total liabilities	25.8M	24.2M	22.2M	25.1M
Current liabilities	—	14.6M	0	16.4M
Accounts payable	—	2.4M	—	3.4M
Accrued expenses	—	—	—	—
Short term debt	—	10.2M	—	10.2M
Deferred revenue	—	—	—	—
Tax payable	—	200.7K	—	204.2K
Pensions	—	86.9K	—	86.9K
Other current liabilities	—	—	—	—
Non current liabilities	—	9.5M	22.2M	8.7M
Long term provisions	—	330.1K	—	154.8K
Long term debt	—	3.2M	—	3.5M
Provision for risks and charges	—	—	—	—
Deferred liabilities	—	2.4M	—	2.2M
Derivative product liabilities	—	—	—	2.9M
Other non current liabilities	—	—	—	—
Shareholders equity
Common stock	—	3.2M	—	3.1M
Retained earnings	—	-16.7M	—	-15.7M
Other shareholders equity	—	—	—	—
Total shareholders equity	96.9M	86.5M	73.8M	81.8M
Additional paid in capital	—	97.7M	—	92.4M
Treasury stock	—	2.1M	—	546.6K
Minority interest	—	—	—	—